Patents by Inventor Se Joon Woo

Se Joon Woo has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Injectable intraocular microgel as drug delivery system, and hydrogel comprising same
    Publication number: 20220387597
    Abstract: Provided are an injectable intraocular microgel and an injectable intraocular hydrogel that are safe to a human body and that can release a drug in the eye for a long period of time. This injectable intraocular microgel may have a form in which a drug is loaded on a hyaluronic acid microgel generated by causing hyaluronic acid copolymers to cross-link with each other through a w/o emulsion method.
    Type: Application
    Filed: October 22, 2020
    Publication date: December 8, 2022
    Inventors: Se Joon Woo, Ki Dong Park, Si Min Lee, Joo Young Son, Wonhee Suh
  • CONTACT LENS HAVING INTEGRATED LIGHT SOURCE FOR ELECTRORETINOGRAPHY AND METHOD FOR PREPARING SAME
    Publication number: 20220322995
    Abstract: The present specification relates to a contact lens having an integrated light source for electroretinography and a method for preparing same, the contact lens, having an integrated light source for electroretinography, comprising: a light source; a scattering material for scattering light from the light source; and an electrode for measuring changes in the electroretinogram due to the stimulation from the light source.
    Type: Application
    Filed: December 2, 2020
    Publication date: October 13, 2022
    Inventors: SE JOON WOO, Seunghyup YOO, Taehyun KIM, Jinouk SONG
  • INTEGRIN ALPHA V BETA 3 TARGETING PROBE FOR DIAGNOSING RETINOCHOROIDAL NEOVASCULAR DISEASES AND PREPARATION METHOD THEREFOR
    Publication number: 20220146519
    Abstract: Provided are: an integrin targeting probe, which can be effectively used for the diagnosis or treatment of retinochoroidal neovascularization or age-related macular degeneration by predicting the occurrence and recurrence of retinochoroidal neovascularization before structural changes of retinochoroidal neovascularization occur; and a preparation method therefor. The integrin targeting probe is an integrin ?v?3 targeting probe for diagnosing retinochoroidal neovascular diseases and can comprise a fluorescent material-labeled cyclic RGD peptide, which is completed by conjugating an NH2-cyclic RGD peptide precursor to a fluorescent material.
    Type: Application
    Filed: November 8, 2019
    Publication date: May 12, 2022
    Inventors: Byung Chul LEE, Jae Ho JUNG, Se Joon WOO, Seong Joon AHN
  • Method of treating eye disease using glycosylated VEGF decoy receptor fusion protein
    Patent number: 9856462
    Abstract: The present application describes an isolated nucleic acid molecule encoding a polypeptide capable of synchronously binding VEGF polypeptide and placenta growth factor (PIGF) polypeptide comprising a nucleotide sequence encoding a VEGFR1 component.
    Type: Grant
    Filed: June 15, 2015
    Date of Patent: January 2, 2018
    Assignees: Korean Advanced Insititute of Science and Technology (KAIST), Seoul National University Bundang Hospital
    Inventors: Ho Min Kim, Hye Kyoung Hong, Se Joon Woo, Eun-Jin Lim, Kyu Hyung Park
  • MARKER FOR DIAGNOSING AGE-RELATED MACULAR DEGENERATION, AND METHOD FOR DIAGNOSING AGE-RELATED MACULAR DEGENERATION BY USING SAME
    Publication number: 20160054335
    Abstract: A biomarker for diagnosing age-related macular degeneration includes a vinculin protein, and a diagnostic kit, a diagnostic method, and a method of screening a therapeutic material for age-related macular degeneration use the biomarker. The diagnostic kit and the diagnostic method of age-related macular degeneration are novel immunological diagnostic tools using the plasma of a patient, and have remarkable sensitivity that enables simple analysis of plasma without a biopsy, and thus can be useful for diagnosing age-related macular degeneration.
    Type: Application
    Filed: March 25, 2014
    Publication date: February 25, 2016
    Applicant: SEOUL NATIONAL UNIVERSITY BUNDANG HOSPITAL
    Inventors: Cheolju LEE, Ji Eun LEE, Hye Jung KIM, Se Joon WOO, Jeeyun AHN, Kyu Hyung PARK, Eui Jin SUH
  • METHOD OF TREATING EYE DISEASE USING GLYCOSYLATED VEGF DECOY RECEPTOR FUSION PROTEIN
    Publication number: 20160024483
    Abstract: The present application describes an isolated nucleic acid molecule encoding a polypeptide capable of synchronously binding VEGF polypeptide and placenta growth factor (PIGF) polypeptide comprising a nucleotide sequence encoding a VEGFR1 component.
    Type: Application
    Filed: June 15, 2015
    Publication date: January 28, 2016
    Inventors: Ho Min KIM, Hye Kyoung Hong, Se Joon Woo, Eun-Jin Lim, Kyu Hyung Park